Altheus Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Phase 2
- Conditions
- Left-sided Ulcerative ColitisUlcerative ColitisDistal Ulcerative Colitis
- Interventions
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Altheus Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT01586533
- Locations
- 🇺🇸
Birmingham Gastroenterology Associates, Birmingham, Alabama, United States
🇺🇸Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸Rocky Mountain Gastroenterology, Lakewood, Colorado, United States
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
- First Posted Date
- 2009-11-24
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- Altheus Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT01020708
- Locations
- 🇺🇸
Oklahoma Foundation for Digestive Research, Oklahoma City, Oklahoma, United States
News
No news found